تحميل...
Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events
BACKGROUND: An increase in serious adverse events with the use of both regular formoterol and regular salmeterol (long-acting beta(2)-agonists) in chronic asthma has been demonstrated in comparison with placebo in previous Cochrane reviews. This increase was significant in trials that did not random...
محفوظ في:
| المؤلفون الرئيسيون: | , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
2010
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4015852/ https://ncbi.nlm.nih.gov/pubmed/20091646 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007694.pub2 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|